Gossamer Bio Inc (NASDAQ:GOSS) has a beta value of 1.86 and has seen 1.08 million shares traded in the last trading session. The company, currently valued at $252.31M, closed the last trade at $1.11 per share which meant it lost -$0.02 on the day or -1.77% during that session. The GOSS stock price is -39.64% off its 52-week high price of $1.55 and 54.95% above the 52-week low of $0.50.
The consensus among analysts is that Gossamer Bio Inc (GOSS) is Buy stock at the moment, with a recommendation rating of 1.44. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 3 out of 10 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight.
Gossamer Bio Inc (NASDAQ:GOSS) trade information
Sporting -1.77% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the GOSS stock price touched $1.11 or saw a rise of 8.26%. Year-to-date, Gossamer Bio Inc shares have moved 22.71%, while the 5-day performance has seen it change -4.31%. Over the past 30 days, the shares of Gossamer Bio Inc (NASDAQ:GOSS) have changed 8.82%.
Wall Street analysts have a consensus price target for the stock at $4, which means that the shares’ value could jump 72.25% from current levels. The projected low price target is $2.0 while the price target rests at a high of $5.0. In that case, then, we find that the current price level is -350.45% off the targeted high while a plunge would see the stock gain -80.18% from current levels.
Gossamer Bio Inc (GOSS) estimates and forecasts
The company’s shares have gained 58.75% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 40.29% over the past 5 years. Earnings growth for 2025 is a modest -168.69% while over the next 5 years, the company’s earnings are expected to increase by 15.97%.
GOSS Dividends
Gossamer Bio Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Gossamer Bio Inc (NASDAQ:GOSS)’s Major holders
The top two institutional holders are NEA MANAGEMENT COMPANY, LLC with over 18.09 million shares worth more than $16.3 million. As of 2024-06-30, NEA MANAGEMENT COMPANY, LLC held 7.9979% of shares outstanding.
The other major institutional holder is ARTAL GROUP S.A., with the holding of over 13.31 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.99 million and represent 5.8832% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Select Portfolios-Biotechnology Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.33% shares in the company for having 7.57 shares of worth $8.41 million while later fund manager owns 6.76 shares of worth $7.51 million as of Mar 31, 2025 , which makes it owner of about 2.98% of company’s outstanding stock.
